Stockhead’s Sarah Hughan sits down with Optiscan Imaging (ASX:OIL) CEO and managing director Dr Camile Farah to get the short end of the long story on the company’s latest news.

The medical technology company has signed a deal with US-based health organisation Mayo Clinic to develop a robot-compatible endomicroscopic imaging system over the next two years.

Robotic-assisted surgery is a rapidly growing multi-billion dollar market and Optiscan is also using its tech to help small animals like cats and dogs!

Tune in to hear Optiscan Imaging’s Dr Farah on the prestigious partnership, its devices pipeline, and more.